Woodline Partners LP Abbott Laboratories Transaction History

Woodline Partners LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $21.9 Million - $26.9 Million	243,244 Added 89.07%	516,340 $56.8 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $26.1 Million - $31.3 Million	273,096 New	273,096 $26.4 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $67.7 Million - $82.9 Million	-586,038 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $68.4 Million - $75.6 Million	586,038 New	586,038 $69.2 Million
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $9.24 Million - $11.8 Million	-120,616 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $7.58 Million - $11.1 Million	120,616 New	120,616 $9.52 Million

3,224

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $224B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.